Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
11/16/1995 | CA2190009A1 Amide derivatives and their therapeutic use |
11/16/1995 | CA2189990A1 Compositions and treatment for multiple sclerosis |
11/16/1995 | CA2189764A1 Neurokinine (tachykinine) antagonists |
11/16/1995 | CA2189340A1 Modulators of cytokines of the tgf-.beta. superfamily and methods for assaying for same |
11/16/1995 | CA2189141A1 Morpholine derivatives and their use as antagonists of tachikinins |
11/16/1995 | CA2188670A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties |
11/16/1995 | CA2186847A1 Adenosine derivatives |
11/15/1995 | EP0682040A1 Humanized immunoglobulins and their production and use |
11/15/1995 | EP0682028A1 5,6-Dihydro-4H-thieno 3,4-C pyrroleerivatives, their preparation and their therapeutic use |
11/15/1995 | EP0682025A1 5,6-dihydro-4H-imidazo 2',1':2,3 imidazo 4,5,1-ij quinoline and 4,5-dihydroimidazo 1,2-a pyrrolo 1,2,3-cd benzimidazol derivatives |
11/15/1995 | EP0681838A1 Analgesic medicinal composition |
11/15/1995 | EP0681833A2 Nasally administrable compositions |
11/15/1995 | EP0681571A1 Spiro-substituted azacycles as tachykinin receptor antagonists |
11/15/1995 | EP0681477A1 Genetic modification of neural stem cells |
11/15/1995 | EP0681474A1 Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |
11/15/1995 | EP0681473A1 Compositions containing tandospirone or its analogs |
11/15/1995 | EP0681472A1 Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents |
11/15/1995 | EP0681471A1 Pharmaceutical compositions comprising cyclodextrin inclusion complexes of the compound ci-979 |
11/15/1995 | EP0536369B1 4-hydroxy butyric acid derivatives |
11/15/1995 | EP0448707B1 Bacteria harboring expression vectors encoding human CILIARY NEUROTROPHIC FACTOR (h-CNTF), their use in the production of h-CNTF, antibodies to h-CNTF and the use of h-CNTF in medical treatment |
11/15/1995 | CN1111907A Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
11/15/1995 | CN1111634A Derivative of thienothiazine |
11/15/1995 | CN1111632A Imidazodiazepine |
11/15/1995 | CN1111626A Preparation and the pharmaceutical compositions which contain them |
11/15/1995 | CN1111620A New alkylaminoindane compounds, processes for preparing them and pharmaceutical compositions containing them |
11/15/1995 | CN1030252C Tetrahydrobenzimidazole derivative |
11/14/1995 | US5466811 Dioxolenylmethyl carbamates pro moieties for amine drugs |
11/14/1995 | US5466713 Iloprost with action against cerebral malaria |
11/14/1995 | US5466709 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes |
11/14/1995 | US5466706 9H-imidazo[1,2-A]benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application |
11/14/1995 | US5466699 (S)-N,N-dimethyl-2-(5-(2-oxo-1,3-oxazolidin -4-ylmethyl)-1H-indole-3-yl)ethylamine; zolmitriptan |
11/14/1995 | US5466698 Substituted tetrahydrophyridines and hydroxypiperidines as central nervous system agents |
11/14/1995 | US5466675 Immunological activity of rhamnolipids |
11/14/1995 | US5466451 Carbon dioxide, supercritical |
11/14/1995 | US5466436 Medicaments for treating inflammatory conditions or for analgesia |
11/14/1995 | CA2045481C Immunosupressing agent and process of producing the same |
11/14/1995 | CA1337548C Fatty acid composition |
11/11/1995 | CA2148951A1 5,6-dihydro-4h-imidazo[2',1':2,3]imidazo-[4,5,1-ij] quinoline and 4,5-dihydroimidazo-[1,2-a]pyrrolo[1,2,3-cd] benzimidazole derivatives, their preparation and application in therapeutics |
11/11/1995 | CA2148880A1 5,6-dihydro-4h-thieno[3,4-c]pyrrole derivatives; process for preparing the same and their use as therapeutic agents |
11/09/1995 | WO1995030004A1 Monoclonal antibodies which promote central nervous system remyelination |
11/09/1995 | WO1995029911A1 Benzofuran derivatives as d4 receptor antagonists |
11/09/1995 | WO1995029909A1 Novel acyclic and cyclic amides as neurotransmitter release enhancers |
11/09/1995 | WO1995029900A1 CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS |
11/09/1995 | WO1995029706A1 TIN-117m-CONTAINING RADIOTHERAPEUTIC AGENTS |
11/09/1995 | WO1995029680A1 New method of treatment |
11/09/1995 | WO1995029672A1 HALOMETHYL AMIDES AS IL-1β PROTEASE INHIBITORS |
11/09/1995 | WO1995029668A1 Nutritional supplement for optimizing cellular health |
11/09/1995 | DE19515650A1 New 8-O-Methyl purpuro-galline carboxylic acid |
11/09/1995 | CA2575042A1 Effective dosage form for antiepileptic drugs |
11/09/1995 | CA2189053A1 Condensed heterocyclic compounds, their production and use as gnrh antagonists |
11/09/1995 | CA2189036A1 Halomethyl amides as il-1.beta. protease inhibitors |
11/09/1995 | CA2188949A1 Benzofuran derivatives as d4 receptor antagonists |
11/08/1995 | EP0680953A1 1-[Styryl]- and 1-[2'-(heteroaryl)-ethenyl]-isoquinoline derivatives, a process for preparing them as well as medicaments containing them and the use of them |
11/08/1995 | EP0680762A1 A pharmaceutical composition, of activity in the treatment of cognitive and/or neuroimmune dysfunctions |
11/08/1995 | EP0680754A2 Percutaneous absorption preparation containing Buprenorphine |
11/08/1995 | EP0680327A1 Therapeutic uses and delivery systems of dehydroepiandrosterone |
11/08/1995 | EP0680326A1 Pharmaceutical composition for treating nicotine dependence. |
11/08/1995 | EP0680321A1 Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
11/08/1995 | EP0502143B1 Composition for treating ocular pain |
11/08/1995 | CN1111247A Protein kinase C inhibitors |
11/08/1995 | CN1111245A Galanthamine derivatives, a process for their preparation and their use as medicaments |
11/08/1995 | CN1111128A Topical anti-inflammatory compositions containing piroxican |
11/07/1995 | US5464872 Sleep disorders |
11/07/1995 | US5464864 3-Methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole, salt, solvate or hydrate; 5-hydroxytryptamine; treatment of migraine or headache |
11/07/1995 | US5464859 Benzospiroalkene derivatives |
11/07/1995 | US5464858 Hypotensive |
11/07/1995 | US5464847 Moduators of corticotropin releasing factor |
11/07/1995 | US5464834 N-substituted N'-heterobicyclic piperazines having pharmaceutical activity |
11/07/1995 | US5464816 Autoimmune disease treatment with nonapeptides |
11/07/1995 | CA2147918A1 Percutaneous absorption preparation |
11/04/1995 | CA2148412A1 1-¬styryl|- and 1-¬2'-(heteroaryl) -ethenyl| -isoquinoline derivatives, a process for preparing them as well as medicaments containing them and the use of them |
11/02/1995 | WO1995029257A2 Apolipoprotein e polymorphism and treatment of alzheimer's disease |
11/02/1995 | WO1995029194A1 Peptides as therapeutic agents for the treatment of auto-immune diseases |
11/02/1995 | WO1995029177A1 Tricyclic derivatives as 5ht2c and 5ht2b antagonists |
11/02/1995 | WO1995029173A1 Naphthalene derivatives, method of preparation and use |
11/02/1995 | WO1995029165A2 Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors |
11/02/1995 | WO1995029159A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
11/02/1995 | WO1995028931A1 Spiro-substituted azacycles as neurokinin-3 antagonists |
11/02/1995 | EP0679717A2 Soluble interferon -receptor, its preparation and use |
11/02/1995 | EP0679645A1 Pharmacologically active CNS pyridmidin compounds |
11/02/1995 | EP0679397A2 Use of substituted amines for the treatment of cerebral insufficiencies |
11/02/1995 | EP0679395A1 Pharmaceutical compositions containing a ketoprofen solution in a soft gelatine capsule and method to produce them |
11/02/1995 | EP0679161A1 Thiazolidine derivatives, preparation thereof and drugs containing same |
11/02/1995 | EP0679090A1 Method for treating myofascial pain syndrome |
11/02/1995 | EP0619809B1 Process for preparing flunixin and intermediates thereof |
11/02/1995 | DE4413938A1 Peptide als Therapeutikum für Autoimmunerkrankungen Peptides as therapeutics for autoimmune diseases |
11/02/1995 | CA2188748A1 Benzocycloalkylazolethione derivatives |
11/02/1995 | CA2188031A1 Spiro-substituted azacycles as neurokinin-3 antagonists |
11/02/1995 | CA2187932A1 Substituted sulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity |
11/01/1995 | CN1110968A Substituted N-piperidino-pyrazole-3-carboxamide |
11/01/1995 | CN1110913A Pharmaceutical composition |
10/31/1995 | US5463074 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring |
10/31/1995 | US5462965 Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases |
10/31/1995 | US5462962 Tetrahydrobenz[c,d]indole serotonin agonists |
10/31/1995 | US5462960 Very good affinity for cannabinoid receptor; having psycho-tropic activity |
10/31/1995 | US5462956 Epibatidine and derivatives, compositions and methods of treating pain |
10/31/1995 | US5462950 Administering raloxifene or salt |
10/31/1995 | US5462948 Treatment of addiction to drugs and substances of abuse |
10/31/1995 | US5462947 Nervous system disorders |
10/31/1995 | US5462945 N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |